We demonstrate in vitro expression of complement components, i.e. C3, facto
r H (FH), factor B (FB), C4, C1-inhibitor (C1-inh), C1q, C5, C6, C7 and C9,
by four human neuroblastoma cell lines IMR32, SKNSH, SH-SY5Y and KELLY, Ac
tivating proteins C4, C9 and Clq, and regulatory proteins FH and C1-inh wer
e produced constitutively by the four cell lines. C3, C6 and FB were mainly
produced by SKNSH and SH-SY5Y, Western blot experiments showed that secret
ed proteins were structurally similar to their serum counterparts. An addit
ional polypeptide of 43 kDa with FH immunoreactivity was detected, which co
uld correspond to the N-terminal truncated form found in plasma. Regulation
of complement expression by inflammatory cytokines, lipopolysaccharide and
dexamethasone was tested in vitro. These factors had no significant effect
s on activating synthesis of components C3, FB and C4, but expression of re
gulating components C1-inh and FH was strongly increased particularly by IF
N-gamma and tumor necrosis factor-alpha. The rate of synthesis of complemen
t components was dependent on the differentiation of neuroblastoma cells. T
his effect of differentiation was also observed on normal rat neurons. Rat
cerebellar granule cells constitutively expressed mRNA for C4 and C1q, but
expression of C3 mRNA was induced by differentiation. This study shows that
neurons could be another local source of complement in the brain, besides
astrocytes and microglia, Human neuroblastoma cell lines can constitute an
interesting model to analyze complement biosynthesis by human neurons. Loca
l complement expression by neurons in vivo may be implicated in some physio
-pathological processes.